Double Blind, Randomized, Placebo Controlled Pilot Study to Evaluate the Effect of Nutritional Supplementation on Physical Activity Performance of Young Soccer Players

March 14, 2024 updated by: Rabin Medical Center

Research has clearly shown that lacking sufficient calories, macro- and micro-nutrients may impair an athlete's training adaptations, while athletes who consume a balanced diet that meets energy needs can enhance physiological training adaptations. Maintaining an energy and nutrient deficient diet during training may lead to loss of muscle mass, strength, and bone mineral density, in addition to an increased susceptibility to illness and injuries, disturbances in immune, endocrine and reproductive function, and an increased prevalence of overreaching and/or overtraining. In children and adolescent athletes, an insufficient diet may additionally result in impaired physical growth. Incorporating good dietary practices as part of a training program is one way to help optimize training adaptations and prevent overtraining.

Based on this, nutritional supplementation is an effective and safe approach for attaining the high nutritional requirements of adolescent athletes, to help them maintain healthy growth. Nutritional supplementation could also improve their body composition, sport performance and general health. The primary objective of the proposed study is to evaluate the effect of dietary supplement versus placebo on growth and physical activity performance in young athletes. A total of 50 young soccer players (25 in each group) will participate in this Double blind, randomized, placebo controlled study.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Petach-Tikva, Israel, 4920235
        • Schnider Children's medical center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 15 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Young soccer players aged 8-15 years old

Exclusion Criteria:

  • Diagnosis of GH Deficiency or treatment with GH
  • Any known chronic disease or dysmorphic syndrome including: organic brain diseases, neurological disease, past or current malignancy, chronic cardiac, renal or pulmonary problems, gastrointestinal disease including malabsorption and bone dysplasia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nutritional supplementation
Powder added to water,high protein and multi vitamin and minerals
Powder added to water,high protein and multi vitamins and minerals
Placebo Comparator: Placebo
Low caloric formula (Powder added to water), without added vitamins and minerals.
Low caloric formula (Powder added to water), without added vitamins and minerals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height SDS (standard deviation score)
Time Frame: at 4 months
Change in standard deviation score of participant's height between baseline and 4 months
at 4 months
10m sprint score
Time Frame: at 4 months
Change in 10m sprint score between baseline and 4 months (test the speed and acceleration of the player)
at 4 months
20m sprint score
Time Frame: at 4 months
Change in 20m sprint score between baseline and 4 months (test the speed and acceleration of the player)
at 4 months
Countermovement Jump (CMJ) score
Time Frame: at 4 months
Change in Countermovement Jump (CMJ) score between baseline and 4 months (assess explosive strength of the lower extremity muscles)
at 4 months
Agility test score
Time Frame: at 4 months
Change in Agility test score between baseline and 4 months(agility is the ability to change the direction of the body rapidly and is a result of a combination of strength, speed, balance and coordination)
at 4 months
The Yo-Yo Intermittent Recovery Test Level 1 (Yo-Yo IR1) score
Time Frame: at 4 months
Change in the Yo-Yo IR1 score between baseline and 4 months (The Yo-Yo IR test measure the ability to recover from intense exercise)
at 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weight-SDS
Time Frame: at 4 months
Change in standard deviation score of subject's weight between baseline and 4 months
at 4 months
BMI-SDS
Time Frame: at 4 months
Change in standard deviation score of subject's BMI between baseline and 4 months
at 4 months

Other Outcome Measures

Outcome Measure
Time Frame
Average daily caloric intake
Time Frame: at 4 months
at 4 months
Average daily macronutrients intake
Time Frame: at 4 months
at 4 months
Average daily micronutrients intake
Time Frame: at 4 months
at 4 months
Average weekly duration of physical activity
Time Frame: at 4 months
at 4 months
Average daily duration of sedentary activity
Time Frame: at 4 months
at 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2020

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

December 26, 2019

First Submitted That Met QC Criteria

December 26, 2019

First Posted (Actual)

December 30, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 14, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RMC0888-18ctil

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth

Clinical Trials on Nutritional Sport Formula

Subscribe